Envoy Medical Inc (COCH)

NASD · Healthcare · Medical Devices · USA

Envoy Medical Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.

Envoy Medical is a hearing health company developing implanted medical technologies for hearing loss. Its investigational Acclaim CI is a fully implanted cochlear implant that uses an implanted sensor to capture sound from the ossicular chain and deliver signals to the cochlea, designed for patients with sensorineural hearing loss.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Envoy Medical Inc stock.

Our verdict on COCH

Overvalued: intrinsic value $1.80 per share, market price $6.87, margin of safety -281.2% (as of 2026-11-17).

A 0.7x revenue multiple, discounted for its losses, values the shares at $1.80; the price of $6.87 is 281% above that value.

ETFs with the most weight in COCH

More on COCH

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than COCH in Medical Devices

47 more in this industry show a wider margin of safety.

Is COCH undervalued or overvalued?

COCH is overvalued (as of the 2026-11-17 close). A 0.7x revenue multiple, discounted for its losses, values the shares at $1.80; the price of $6.87 is 281% above that value.

What is the intrinsic value of COCH?

$1.80 per share (as of the 2026-11-17 close), against a market price of $6.87. That is a margin of safety of -281.2%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.